Form 8-K - Current report:
SEC Accession No. 0001213900-25-029418
Filing Date
2025-04-07
Accepted
2025-04-07 16:13:14
Documents
17
Period of Report
2025-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237310-8k_incannex.htm   iXBRL 8-K 33643
2 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C ea023731001ex5-1_incannex.htm EX-5.1 11991
3 SALES AGREEMENT, DATED APRIL 7, 2025, BY AND BETWEEN INCANNEX HEALTHCARE INC. AN ea023731001ex10-1_incannex.htm EX-10.1 221583
4 GRAPHIC ex5-1_001.jpg GRAPHIC 5938
5 GRAPHIC ex5-1_002.jpg GRAPHIC 3121
  Complete submission text file 0001213900-25-029418.txt   519823

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ixhl-20250407.xsd EX-101.SCH 3014
7 XBRL LABEL FILE ixhl-20250407_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE ixhl-20250407_pre.xml EX-101.PRE 22358
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0237310-8k_incannex_htm.xml XML 3787
Mailing Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153
Business Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 25818274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)